These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26591725)

  • 41. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
    J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage II-III breast cancer: treatment intervals and clinical outcomes.
    Wright JL; Cordeiro PG; Ben-Porat L; Van Zee KJ; Hudis C; Beal K; McCormick B
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):43-50. PubMed ID: 17855006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
    Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.
    Kapoor NS; Shamonki J; Sim MS; Chung CT; Giuliano AE
    Ann Surg Oncol; 2013 Aug; 20(8):2576-81. PubMed ID: 23468047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment patterns and affecting factors in breast cancer patients over 65-years of age].
    Mao Y; Chen X; Gao W; Liu J; Shen K
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):366-71. PubMed ID: 25030593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group.
    Hannoun-Levi JM; Resch A; Gal J; Kauer-Dorner D; Strnad V; Niehoff P; Loessl K; Kovács G; Van Limbergen E; Polgár C;
    Radiother Oncol; 2013 Aug; 108(2):226-31. PubMed ID: 23647758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
    Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
    Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
    Gnant M; Mlineritsch B; Stoeger H; Luschin-Ebengreuth G; Heck D; Menzel C; Jakesz R; Seifert M; Hubalek M; Pristauz G; Bauernhofer T; Eidtmann H; Eiermann W; Steger G; Kwasny W; Dubsky P; Hochreiner G; Forsthuber EP; Fesl C; Greil R;
    Lancet Oncol; 2011 Jul; 12(7):631-41. PubMed ID: 21641868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathological patterns and challenges of management of colorectal cancer in a resource-limited setting: a Tanzanian experience.
    Chalya PL; McHembe MD; Mabula JB; Rambau PF; Jaka H; Koy M; Mkongo E; Masalu N
    World J Surg Oncol; 2013 Apr; 11():88. PubMed ID: 23597032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic factors for elderly breast cancer patients in University Malaya Medical Centre, Malaysia.
    Phua CE; Bustam AZ; Yip CH; Taib NA
    Asian Pac J Cancer Prev; 2010; 11(5):1205-11. PubMed ID: 21198264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Head and neck cancers: a clinico-pathological profile and management challenges in a resource-limited setting.
    Gilyoma JM; Rambau PF; Masalu N; Kayange NM; Chalya PL
    BMC Res Notes; 2015 Dec; 8():772. PubMed ID: 26654449
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathological features of Breast Cancer seen in Northwestern Tanzania: a nine years retrospective study.
    Rambau PF; Chalya PL; Manyama MM; Jackson KJ
    BMC Res Notes; 2011 Jun; 4():214. PubMed ID: 21696617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Challenges in the Management of Breast Cancer in a Low Resource Setting in South East Asia.
    Ley P; Hong C; Varughese J; Camp L; Bouy S; Maling E
    Asian Pac J Cancer Prev; 2016; 17(7):3459-63. PubMed ID: 27509992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endoscopic and clinicopathological patterns of esophageal cancer in Tanzania: experiences from two tertiary health institutions.
    McHembe MD; Rambau PF; Chalya PL; Jaka H; Koy M; Mahalu W
    World J Surg Oncol; 2013 Oct; 11():257. PubMed ID: 24094270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pattern of prognostic and risk indicators among women with breast cancer undergoing modified radical mastectomy in Dar es Salaam, Tanzania.
    Mwakigonja AR; Rabiel H; Mbembati NA; Lema LE
    Infect Agent Cancer; 2016; 11():28. PubMed ID: 27366204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Invasive breast Cancer treatment in Tanzania: landscape assessment to prepare for implementation of standardized treatment guidelines.
    Sood R; Masalu N; Connolly RM; Chao CA; Faustine L; Mbulwa C; Anderson BO; Rositch AF
    BMC Cancer; 2021 May; 21(1):527. PubMed ID: 33971839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presenting features, treatment patterns and outcomes of patients with breast cancer in Pakistan: Experience at a university hospital.
    Kumar S; Shaikh AJ; Rashid YA; Masood N; Mohammed A; Malik UZ; Haider G; Niamutullah N; Khan S
    Indian J Cancer; 2016; 53(2):230-234. PubMed ID: 28071616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical assessment of 324 breast cancer cases in two centers between the years of 1992 and 2002.
    Borazan A; Ustün H; Aksoy F; Vatansev C; Cantürk Z; Akkaş M; Ecirli S; Yilmaz A
    Acta Medica (Hradec Kralove); 2003; 46(4):195-9. PubMed ID: 14965173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.